118 related articles for article (PubMed ID: 10409713)
1. Fiz1, a novel zinc finger protein interacting with the receptor tyrosine kinase Flt3.
Wolf I; Rohrschneider LR
J Biol Chem; 1999 Jul; 274(30):21478-84. PubMed ID: 10409713
[TBL] [Abstract][Full Text] [Related]
2. Interaction of retinal bZIP transcription factor NRL with Flt3-interacting zinc-finger protein Fiz1: possible role of Fiz1 as a transcriptional repressor.
Mitton KP; Swain PK; Khanna H; Dowd M; Apel IJ; Swaroop A
Hum Mol Genet; 2003 Feb; 12(4):365-73. PubMed ID: 12566383
[TBL] [Abstract][Full Text] [Related]
3. p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells.
Zhang S; Broxmeyer HE
Biochem Biophys Res Commun; 1999 Jan; 254(2):440-5. PubMed ID: 9918857
[TBL] [Abstract][Full Text] [Related]
4. Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells.
Zhang S; Mantel C; Broxmeyer HE
J Leukoc Biol; 1999 Mar; 65(3):372-80. PubMed ID: 10080542
[TBL] [Abstract][Full Text] [Related]
5. Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells.
Dosil M; Wang S; Lemischka IR
Mol Cell Biol; 1993 Oct; 13(10):6572-85. PubMed ID: 7692230
[TBL] [Abstract][Full Text] [Related]
6. FLT3 signaling in hematopoietic cells involves CBL, SHC and an unknown P115 as prominent tyrosine-phosphorylated substrates.
Lavagna-Sévenier C; Marchetto S; Birnbaum D; Rosnet O
Leukemia; 1998 Mar; 12(3):301-10. PubMed ID: 9529123
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol-3' kinase is not required for mitogenesis or internalization of the Flt3/Flk2 receptor tyrosine kinase.
Beslu N; LaRose J; Casteran N; Birnbaum D; Lecocq E; Dubreuil P; Rottapel R
J Biol Chem; 1996 Aug; 271(33):20075-81. PubMed ID: 8702727
[TBL] [Abstract][Full Text] [Related]
8. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity.
Lioubin MN; Algate PA; Tsai S; Carlberg K; Aebersold A; Rohrschneider LR
Genes Dev; 1996 May; 10(9):1084-95. PubMed ID: 8654924
[TBL] [Abstract][Full Text] [Related]
9. Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase.
Rottapel R; Turck CW; Casteran N; Liu X; Birnbaum D; Pawson T; Dubreuil P
Oncogene; 1994 Jun; 9(6):1755-65. PubMed ID: 8183574
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase.
Maroc N; Rottapel R; Rosnet O; Marchetto S; Lavezzi C; Mannoni P; Birnbaum D; Dubreuil P
Oncogene; 1993 Apr; 8(4):909-18. PubMed ID: 8384358
[TBL] [Abstract][Full Text] [Related]
11. FLT3/ITD mutation signaling includes suppression of SHP-1.
Chen P; Levis M; Brown P; Kim KT; Allebach J; Small D
J Biol Chem; 2005 Feb; 280(7):5361-9. PubMed ID: 15574429
[TBL] [Abstract][Full Text] [Related]
12. Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation.
Kong M; Wang CS; Donoghue DJ
J Biol Chem; 2002 May; 277(18):15962-70. PubMed ID: 11827956
[TBL] [Abstract][Full Text] [Related]
13. Expression and signal transduction of the FLT3 tyrosine kinase receptor.
Rosnet O; Bühring HJ; deLapeyrière O; Beslu N; Lavagna C; Marchetto S; Rappold I; Drexler HG; Birg F; Rottapel R; Hannum C; Dubreuil P; Birnbaum D
Acta Haematol; 1996; 95(3-4):218-23. PubMed ID: 8677746
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene.
Lyman SD; James L; Zappone J; Sleath PR; Beckmann MP; Bird T
Oncogene; 1993 Apr; 8(4):815-22. PubMed ID: 7681159
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the mitogenic pathway of the FLT3 receptor and characterization in its C terminal region of a specific binding site for the PI3' kinase.
Casteran N; Rottapel R; Beslu N; Lecocq E; Birnbaum D; Dubreuil P
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):443-56. PubMed ID: 7920189
[TBL] [Abstract][Full Text] [Related]
16. Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules.
Ito N; Wernstedt C; Engström U; Claesson-Welsh L
J Biol Chem; 1998 Sep; 273(36):23410-8. PubMed ID: 9722576
[TBL] [Abstract][Full Text] [Related]
17. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation.
Latour S; Roncagalli R; Chen R; Bakinowski M; Shi X; Schwartzberg PL; Davidson D; Veillette A
Nat Cell Biol; 2003 Feb; 5(2):149-54. PubMed ID: 12545173
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells.
Morra M; Lu J; Poy F; Martin M; Sayos J; Calpe S; Gullo C; Howie D; Rietdijk S; Thompson A; Coyle AJ; Denny C; Yaffe MB; Engel P; Eck MJ; Terhorst C
EMBO J; 2001 Nov; 20(21):5840-52. PubMed ID: 11689425
[TBL] [Abstract][Full Text] [Related]
19. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
[TBL] [Abstract][Full Text] [Related]
20. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
